A clinical case series of switching from antipsychotic polypharmacy to monotherapy with a second-generation agent on patients with chronic schizophrenia.

Source:http://linkedlifedata.com/resource/pubmed/id/14751434

Download in:

View as

General Info

PMID
14751434